EPFL team unveils unified 3D generative model for structure-based drug design and docking
HannesStaerk · x · 2026-11-20
Researchers from EPFL (Igashov, Schneuing, Correia, with Bronstein and Schwaller among co-authors) released a bioRxiv preprint on a unified 3D generative model for synthesizable structure-based drug design. Using BRICS fragmentation plus masked modeling on protein-ligand complexes, one model handles de novo design, docking, joint design+docking, fragment-based design, and constrained docking — controlling flexibly which atoms, bonds, or 3D coordinates are generated. The team presented it on the Starkly Speaking Zoom seminar.
More from Embodied
- GXO's 1,000-robot Apptronik deal is a letter of intent, hinging on 4 years of KPIs — YvesMulkers · 2026-11-20
- NVIDIA's SOMA Retargeter adapts human motion to five humanoid robots, from G1 to AgiBot — jonstephens85 · 2026-11-20
- AFFECT from KAIST makes world models dynamics-faithful via action effect matching — John Won · 2026-11-20
- Mind2Act World: a 180-task benchmark exposing robots' mind-action composition failures — Mind2Act-World · 2026-11-20
- ZeroVLN navigates without SFT of the VLM brain using tool-calling and closed-loop RL — ZYT-AI · 2026-11-20
- Robot Paper Club recordings go live with four post-training talks; World Models edition next — DominiqueCAPaul · 2026-11-20